Paroxetine Tablet (Extended-Release) Suppliers & Bulk Manufacturers

Available Forms: Tablet (Extended-Release)

Available Strengths: 12.5 mg, 25 mg, 37.5 mg

Reference Brands: US: Paxil®, Pexeva®, Brisdelle®; EU: Seroxat®, ParoMerck®, Paxetin®

Category: Antipsychotropic Drugs

Paroxetine Tablet (Extended-Release) is available in Tablet (Extended-Release) and strengths such as 12.5 mg, 25 mg, 37.5 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Paroxetine Tablet (Extended-Release) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Paroxetine Tablet (Extended-Release) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Paroxetine extended-release tablets are FDA-approved in the USA for treating major depressive disorder (MDD), panic disorder, social anxiety disorder, and generalized anxiety disorder. As a selective serotonin reuptake inhibitor (SSRI), they require a Boxed Warning for increased suicidality risk in young adults, along with compliance to GMP, labeling regulations, and post-marketing surveillance under FDA’s pharmacovigilance programs. In the EU, while immediate-release formulations are more common, extended-release versions must meet EMA or national agency approval standards, including Risk Management Plans (RMPs) and Periodic Safety Update Reports (PSURs). Explore dossier-ready supplies at Pharmatradz.com.